-
PDF
- Split View
-
Views
-
Cite
Cite
Manar Asad Khan, Afzal Anees, Meraj Ahmed, Hazique Jameel, Esophageal pendulum: a rare case report of a giant solitary fibrous tumor of the esophagus, Journal of Surgical Case Reports, Volume 2026, Issue 10, October 2026, rjag673, https://doi.org/10.1093/jscr/rjag673
Close - Share Icon Share
Abstract
Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm, accounting for <2% of soft-tissue tumors. Initially described in the pleura, it can arise at various extra pleural sites. Identification of the NAB2–STAT6 fusion gene has improved diagnostic accuracy. Complete surgical excision remains the treatment of choice. A 21-year-old female presented with progressive dysphagia and refractory anemia for six months. Imaging revealed a well-circumscribed intraluminal esophageal mass extending from the cervical to mid-thoracic esophagus and prolapsing into the stomach. The tumor was excised via an open left cervical approach with transgastric extraction. Histology showed spindle cells with CD34 and SMA positivity and nuclear STAT6 positivity, confirming SFT. Recovery was uneventful with no recurrence on follow-up, highlighting the importance of complete excision and immunohistochemical evaluation.
Introduction
Solitary fibrous tumor (SFT) is a rare soft tissue tumor of mesenchymal origin. Originally described in pleural tumors by Klemperer and Rabin in 1931, with ~800 cases reported in the literature between 1931 and 2002 [1, 2]. It usually originates from the visceral pleura (85%–90% of SFT cases), but in recent years, this type of neoplasm has also been reported to occur at numerous extrathoracic sites. With gross and histologic features that overlap with many other soft tissue tumors, SFT have been assigned many different names in the past including benign mesothelioma, localized mesothelioma, solitary fibrous mesothelioma, and localized fibrous tumor to name a few.
SFTs being typically CD34 and STAT6 positive, can occur anywhere along the esophagus and are generally benign, though occasional malignant variants exist. The rarity of these tumors in the esophagus, particularly in young individuals, makes preoperative classification difficult. Therefore, complete surgical excision remains both diagnostic and curative, allowing for thorough histopathologic assessment and immunohistochemical confirmation. Minimally invasive and endoscopic techniques are emerging options, but histological evaluation remains essential for definitive diagnosis. Radiation and chemotherapy have limited roles, mainly reserved for unresectable or metastatic cases, making surgery the cornerstone of management [3].
Case presentation
A 21-year-old female presented with progressive difficulty in swallowing corresponding to Mellow-Pinkas grade II initially, progressing to grade III (initially solids, later semisolids and liquids) and easy fatiguability since past 6 months. There was occasional regurgitation of undigested food and intermittent retrosternal discomfort after meals. There was no history of aspiration episodes, recurrent respiratory tract infections, cough, dyspnea, hoarseness, odynophagia, nocturnal choking, melena, hematemesis or any menstrual cycle abnormalities. Appetite was relatively preserved and there was no significant documented weight loss. There was no family history of malignancy or any past history of radiation exposure.
General examination
Pallor- Present.
No palpable lymphadenopathy.
Nutritional Status: Underweight with BMI: 18.2 kg/m2.
Vitals were stable with no evidence of respiratory compromise.
Systemic examination
Cardiovascular and respiratory examinations were unremarkable. Abdominal examination did not reveal organomegaly or palpable mass. Higher mental functions were intact with no sensory/motor deficit.
Laboratory investigations
Hemoglobin: 7.8 g/dL (microcytic, hypochromic).
Iron studies consistent with iron deficiency.
Liver and coagulation profile: Normal.
Endoscopic study and imaging:
Upper GI endoscopy: Long polypoidal smooth submucosal growth arising from the cervical to mid-thoracic esophagus (~18–30 cm from incisors); extending beyond GE junction with a pendulous base with minimally ulcerated mucosa and luminal narrowing as shown in Figs 1 and 2.

Endoscopy showing long solitary polypoidal mass arising from cervical and mid thoracic esophagus and extending beyond GE junction with pendulous base as shown.

Endoscopy showing long solitary polypoidal mass arising from cervical and mid thoracic esophagus and extending beyond GE junction with pendulous base as shown.
Barium swallow (esophagogram): Gross dilatation of thoracic oesophagus with filling defect within it. GE junction appears normal, no significant narrowing seen as depicted in Fig. 3.

Barium swallow reveals a large, smooth-margined, elongated filling defect in mid-to-lower thoracic esophagus causing significant luminal narrowing and proximal esophageal dilation. The lesion shows features consistent with a submucosal mass, likely a benign etiology, with no evidence of mucosal ulceration or fistula.
Contrast-enhanced CT (Neck+Thorax+Abdomen): Well-defined endoluminal soft tissue density lesion arising from right lateral wall of thoracic esophagus extending from T1-T8 (size ~6.9 × 3.9 × 12 cm)without necrosis, lymphadenopathy, or distant metastasis.as shown in Fig. 4a–c.

(a) Axial cut of mediastinal and lung window showing a well-defined, soft tissue density mass seen in the posterior mediastinum, closely abutting the esophagus. (b and c) Sagittal and coronal section demonstrates a well-defined, elongated soft tissue mass measuring ~12 cm in cranio-caudal length, extending from the thoracic inlet to the diaphragm. No definite invasion to adjacent structures or any associated lymphadenopathy or effusion seen.
Differentials: Based on the clinical presentation and imaging findings, differential diagnoses considered included giant fibrovascular polyp, esophageal leiomyoma, gastrointestinal stromal tumor (GIST), inflammatory fibroid polyp and other spindle-cell mesenchymal tumors.
Surgical management
After multidisciplinary approach, patient underwent left cervical exploration with complete excision and transgastric extraction of the tumor. Intraoperative photographs (Fig. 5a–c) demonstrates the technique of exposure and gross morphology of the tumor.

(a) Intraoperative exposure of upper esophagus via open cervical approach and careful identification and mobilization of gross tumor along with neurovascular structures. (b) Intraoperative midline incision given and tumor extracted through gastrostomy. (c) Macroscopically, the tumor appeared lobulated and well-circumscribed, elastic and firm mass that measured ~15 x 6 x 2 cm with visible proximal stalk.
The patient was positioned supine with neck extension. Through a left cervical incision along the anterior border of the sternocleidomastoid muscle, the cervical esophagus was carefully mobilized while preserving adjacent neurovascular structures, including the recurrent laryngeal nerve and carotid sheath contents. Intraoperatively, the tumor was identified as a large pedunculated intraluminal mass arising from the upper thoracic esophagus.
An upper midline laparotomy with anterior gastrostomy was performed due to considerable tumor length and distal extension beyond the gastroesophageal junction. The distal end of the tumor was gently delivered into the stomach and extracted through the gastrostomy under direct visualization. The pedicle was ligated and divided at its esophageal attachment, allowing complete en bloc excision.
Histopathological evaluation
Gross pathology: The excised specimen measured ~15 × 6 × 3 cm. The cut surface was firm, homogeneously pale, with no necrosis.
Microscopy (H&E): Spindle-shaped cells arranged in fascicles or interlacing bundles, bland nuclear features, absence of significant mitotic activity, no nuclear pleomorphism, no necrosis.
Immunohistochemistry: Diffuse positivity for SMA, Positive for CD34, Negative for CD 117 and strong nuclear positivity for STAT 6 making a provisional diagnosis of SFT. Histopathological examination (Fig. 6a–d) confirmed benign spindle cell tumor, specific type solitary fibrous tumor.

(a) High power (40×) view showing numerous elongated, spindle-shaped tumor cells with robust cytoplasmic brown staining, indicating immunoreactivity for SMA suggestive of myofibroblastic lesion. (b) High power (40×) view showing scattered spindle and stellate-shaped tumor cells with diffuse, membranous and cytoplasmic brown staining, indicative of strong CD34 immunopositivity suggestive of mesenchymal origin. (c) High power view showing absence of brown membranous or cytoplasmic staining in the spindle shaped tumor cells, indicating CD117 negativity that helps exclude GIST as a differential. (d) High power view showing numerous spindle-shaped tumor cells with clear nuclear brown staining, consistent with STAT6 positivity. Cytoplasmic staining is absent, supporting the specific nuclear localization characteristic of the NAB2-STAT6 gene fusion in solitary fibrous tumors.
Postoperative period and follow up
The patient was kept nil per oral postoperatively. A Day-5 contrast study showed no leak, and oral intake was resumed. The chest drain was removed on Day 6, and she was discharged on Day 8. At 6-month follow-up, she remains asymptomatic with improved hemoglobin and no recurrence.
Discussion and review of literature
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that were historically described in the pleura but are now recognized at multiple extrapleural sites, including the mediastinum, abdomen, head and neck, and spine [1, 2]. Esophageal involvement is exceptionally uncommon, resulting in diagnostic and therapeutic challenges. Fewer than 100 cases have been reported worldwide, with most patients presenting in the fifth decade of life and no clear sex predilection [4]. In contrast, our patient was a 21-year-old female, highlighting the unusual age at presentation.as discussed in Table 1.
| Author (year) . | Age / sex . | Tumor type . | Size & location . | Treatment / resection method . | IHC / Molecular Findings . | Outcome / follow-up . |
|---|---|---|---|---|---|---|
| Zhu XS et al. (2015) [3] | 52 / F | SFT | 7 cm, mid-esophagus | Endoscopic submucosal dissection (ESD) | CD34+, STAT6+, Bcl-2+ | Uneventful recovery, no recurrence at 1 yr |
| Mubarak MF et al. (2018) [9] | 60 / M | SFT | 8 cm, lower esophagus | Endoscopic resection (ESD-assisted) | CD34+, STAT6+, CD99+ | Discharged Day 3, disease-free at 12 mo |
| Li H et al. (2009) [4] | 64 / F | SFT | 10 cm, lower esophagus | Open enucleation | CD34+, CD99+, Bcl-2+, STAT6+ | No recurrence at 18 mo |
| Mardani P et al. (2023) [10] | 45 / F | SFT (posterior mediastinal) | 15 cm, extending to esophagus | Thoracotomy and complete excision | CD34+, STAT6 nuclear + | Recovered well, recurrence-free at 2 yrs |
| D’Amico FE et al. (2017) [11] | 51 / M | SFT | 5 cm, submucosal mid-thoracic | Local excision | CD34+, STAT6+, Bcl-2+ | No recurrence at 3 yrs |
| Li J et al. (2024) [12] | 58 / M | Malignant SFT | 18 cm, thoracic | Surgical excision | STAT6+, high mitotic index | Highlighted risk stratification, recurrence potential |
| Author (year) | Age / sex | Tumor type | Size & location | Treatment / resection method | IHC / Molecular Findings | Outcome / follow-up |
|---|---|---|---|---|---|---|
| Zhu XS et al. (2015) [ | 52 / F | SFT | 7 cm, mid-esophagus | Endoscopic submucosal dissection (ESD) | CD34+, STAT6+, Bcl-2+ | Uneventful recovery, no recurrence at 1 yr |
| Mubarak MF et al. (2018) [ | 60 / M | SFT | 8 cm, lower esophagus | Endoscopic resection (ESD-assisted) | CD34+, STAT6+, CD99+ | Discharged Day 3, disease-free at 12 mo |
| Li H et al. (2009) [ | 64 / F | SFT | 10 cm, lower esophagus | Open enucleation | CD34+, CD99+, Bcl-2+, STAT6+ | No recurrence at 18 mo |
| Mardani P et al. (2023) [ | 45 / F | SFT (posterior mediastinal) | 15 cm, extending to esophagus | Thoracotomy and complete excision | CD34+, STAT6 nuclear + | Recovered well, recurrence-free at 2 yrs |
| D’Amico FE et al. (2017) [ | 51 / M | SFT | 5 cm, submucosal mid-thoracic | Local excision | CD34+, STAT6+, Bcl-2+ | No recurrence at 3 yrs |
| Li J et al. (2024) [ | 58 / M | Malignant SFT | 18 cm, thoracic | Surgical excision | STAT6+, high mitotic index | Highlighted risk stratification, recurrence potential |
Clinical manifestations of esophageal SFTs are largely related to luminal obstruction rather than intrinsic tumor biology. Progressive dysphagia is the most common symptom and may be associated with nonspecific features such as anemia-related fatigue, weight loss, or retrosternal discomfort [4, 5]. Because these tumors arise from the submucosa and typically preserve an intact mucosa, endoscopic biopsies are frequently nondiagnostic [3]. Radiologically, SFTs appear as smooth, well-circumscribed intraluminal masses without invasion of adjacent structures, often mimicking leiomyoma or GIST. Histopathological and immunohistochemical evaluation remains essential for definitive diagnosis. SFTs are characterized by spindle-cell proliferation in a ‘patternless’ arrangement with alternating hypocellular and hypercellular areas within a collagenous stroma [6]. CD34 positivity is observed in most cases but lacks specificity [7]. The identification of the NAB2–STAT6 fusion gene and corresponding nuclear STAT6 immunoreactivity provides high sensitivity and specificity for SFT diagnosis [3]. In the present case, strong nuclear STAT6 positivity confirmed the diagnosis and excluded close histologic mimics [6].
Complete surgical excision remains the standard and most effective treatment for localized SFTs [5]. Minimally invasive techniques including endoscopic submucosal dissection have been successfully used for smaller lesions (<7–8 cm), as reported by Zhu et al. and Mubarak et al. [3], giant tumors pose significant technical challenge often necessitating open approaches [4]. Our combined cervical and transgastric approach enabled complete excision of a 15 cm tumor while preserving esophageal continuity.
Although most SFTs behave indolently, malignant potential and late recurrence have been reported, particularly in large tumors [7, 8]. Therefore, long-term surveillance is recommended. This case underscores the importance of considering SFT in large esophageal masses and highlights the role of STAT6-based diagnosis and organ-preserving surgical management.
Conclusion
Solitary fibrous tumor is a rare, slow-growing neoplasm distinguished by advances in molecular diagnostics. Complete surgical excision is the primary treatment for localized disease with favorable outcomes. The roles of radiotherapy and systemic therapy in advanced cases remain evolving and require multidisciplinary evaluation and further research.
Author contributions
Manar Asad Khan collected clinical data and drafted the manuscript. Afzal Anees and Meraj Ahmed assisted in surgery and provided clinical insight. Hazique Jameel reviewed the pathology and immunohistochemistry and revised the manuscript. All authors read and approved the final version.
Conflicts of interest
None declared.
Funding
No funding was received for this case report.
Data availability
All data generated or analyzed during this case are included in this manuscript.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Ethics statement
The study was performed according to the Helsinki Declaration and institutional ethical committee clearance was taken.